Semaglutide and tirzepatide are GLP-1 receptor agonists (tirzepatide also targets GIP receptors) approved for weight management and type 2 diabetes
Bone density considerations also come into play, as bone health during GLP-1 treatment requires adequate calcium and vitamin D intake
In the eWAT, no group separation was observed in the PCA, and only five and three proteins were upregulated by GLP-1GIPLani and GLP-1GIP, respectively (Extended Data Fig
The front of the thigh The upper outer quadrant of the thigh provides a large surface area with adequate subcutaneous tissue
stable for up to 24 months [16]
Dr Kenneth Custer, executive VP and president of Lilly Cardiometabolic Health, said: Across five positive Phase III studies, retatrutide has shown powerful efficacy, and we believe it could be an important future tool in the management of cardiometabolic health